Inventor · disambiguated record
Peter L. Collins
Also filed as: COLLINS PETER · COLLINS PETER L
63 granted patents·22 pending applications·948 citations·filing 1988–2025
99Inventor score
Files withUS HEALTH51THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES4THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES3THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC3COLLINS PETER L2
Top patents by PatentIndex Score
85 records- 0197US6790449B2Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteinsUS HEALTH·Filed 2001·Granted Sep 14, 2004·67 cites·24 claims
- 0295US7589180B2Specific binding proteins and uses thereofLUDWIG INST CANCER RES·Filed 2002·Granted Sep 15, 2009·70 cites·4 claims
- 0393US6699476B1Production of recombinant respiratory syncytial viruses expressing immune modulatory moleculesFiled 2000·Granted Mar 2, 2004·46 cites·78 claims
- 0492US7846455B2Attenuated chimeric respiratory syncytial virusUS HEALTH·Filed 2003·Granted Dec 7, 2010·36 cites·11 claims
- 0592US6264957B1Product of infectious respiratory syncytial virus from cloned nucleotide sequencesUS HEALTH·Filed 1996·Granted Jul 24, 2001·75 cites·22 claims
- 0692US5149650AVaccines for human respiratory virusUNIV NORTH CAROLINA·Filed 1988·Granted Sep 22, 1992·109 cites·26 claims
- 0791US7951383B2Attenuated parainfluenza virus (PIV) vaccinesUS HEALTH·Filed 2007·Granted May 31, 2011·14 cites·2 claims
- 0890US11591372B2Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereofUS HEALTH·Filed 2020·Granted Feb 28, 2023·2 cites·15 claims
- 0990US10420834B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2015·Granted Sep 24, 2019·4 cites·53 claims
- 1090US9957486B2Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimizationUS HEALTH·Filed 2014·Granted May 1, 2018·9 cites·12 claims
- 1190US7744902B2Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genesUS HEALTH·Filed 2005·Granted Jun 29, 2010·7 cites·4 claims
- 1290US6713066B1Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2US HEALTH·Filed 2000·Granted Mar 30, 2004·43 cites·63 claims
- 1389US10808012B2Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Oct 20, 2020·4 cites·20 claims
- 1489US7632508B2Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccinesUS HEALTH·Filed 2006·Granted Dec 15, 2009·10 cites·21 claims
- 1588US12233124B2Recombinant metapneumovirus f proteins and their useUS HEALTH·Filed 2023·Granted Feb 25, 2025·0 cites·35 claims
- 1688US11371024B2Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimizationTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Jun 28, 2022·3 cites·17 claims
- 1788US7709007B2Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 2004·Granted May 4, 2010·18 cites·46 claims
- 1888US7704509B2Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogensUSA·Filed 2002·Granted Apr 27, 2010·27 cites·270 claims
- 1987US9937196B2Genomic sequence of avian paramyxovirus type 2 and uses thereofSAMAL SIBA K·Filed 2010·Granted Apr 10, 2018·17 cites·14 claims
- 2087US7192593B2Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogensUS HEALTH·Filed 2000·Granted Mar 20, 2007·23 cites·43 claims
- 2186US7662397B2Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genesUS HEALTH·Filed 2005·Granted Feb 16, 2010·4 cites·34 claims
- 2286US6923971B2Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genesUS HEALTH·Filed 2001·Granted Aug 2, 2005·15 cites·81 claims
- 2386US5993824AProduction of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1997·Granted Nov 30, 1999·69 cites·17 claims
- 2485US8367074B2Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogensUS SEC THE DEPT OF HEALTH & HUMAN SERVICES·Filed 2007·Granted Feb 5, 2013·5 cites·11 claims
- 2583US12018051B2Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereofUS HEALTH·Filed 2023·Granted Jun 25, 2024·0 cites·20 claims
- 2683US7622123B2Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccinesUS HEALTH·Filed 2004·Granted Nov 24, 2009·12 cites·36 claims
- 2783US7244558B1Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccinesUS HEALTH·Filed 2000·Granted Jul 17, 2007·12 cites·10 claims
- 2883US7201907B1Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccinesUS HEALTH·Filed 2000·Granted Apr 10, 2007·17 cites·46 claims
- 2983US2024417431A1Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypesTHE US SECRETARY DEPARTMENT OF HE·Filed 2024·Application pending·0 cites
- 3083US2024417699A1Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimizationTHE US SECRETARY DEPARTMENT OF HE·Filed 2024·Application pending·0 cites
- 3183US2024309053A1Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/piv3 f protein and uses thereofTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 3282US7704491B2Recombinant human metapneumovirus and its useUS HEALTH·Filed 2004·Granted Apr 27, 2010·11 cites·8 claims
- 3380US12054519B2Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2022·Granted Aug 6, 2024·0 cites·20 claims
- 3480US7208161B1Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1998·Granted Apr 24, 2007·37 cites·70 claims
- 3579US12054749B2Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimizationTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2022·Granted Aug 6, 2024·0 cites·20 claims
- 3679US10307476B2Genetically stable live attenuated respiratory syncytial virus vaccine and its productionUS HEALTH·Filed 2017·Granted Jun 4, 2019·1 cites·22 claims
- 3779US7842798B2Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccinesUS HEALTH·Filed 2005·Granted Nov 30, 2010·3 cites·15 claims
- 3879US7485440B2Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2US HEALTH·Filed 2004·Granted Feb 3, 2009·7 cites·11 claims
- 3977US11786591B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2021·Granted Oct 17, 2023·0 cites·36 claims
- 4077US6689367B1Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequencesUS HEALTH·Filed 1999·Granted Feb 10, 2004·46 cites·51 claims
- 4176US11027007B2Recombinant metapneumovirus F proteins and their useUS HEALTH·Filed 2019·Granted Jun 8, 2021·0 cites·37 claims
- 4276US2024392317A1Chimeric vectorsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 4375US10654898B2Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereofUS HEALTH·Filed 2016·Granted May 19, 2020·1 cites·30 claims
- 4475US7820182B2Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositionsUS HEALTH·Filed 2003·Granted Oct 26, 2010·5 cites·11 claims
- 4575US7465794B2Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory moleculesUS HEALTH·Filed 2004·Granted Dec 16, 2008·4 cites·63 claims
- 4675US2025387464A1Recombinant metapneumovirus f proteins and their useTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 4774US10980872B2Genetically stable live attenuated respiratory syncytial virus vaccine and its productionUS HEALTH·Filed 2019·Granted Apr 20, 2021·0 cites·23 claims
- 4872US6410023B1Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential geneUS HEALTH·Filed 1999·Granted Jun 25, 2002·28 cites·53 claims
- 4972US6270958B1Detection of negative-strand RNA virusesUNIV WASHINGTON·Filed 1999·Granted Aug 7, 2001·47 cites·21 claims
- 5070US11390651B2Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypesTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Jul 19, 2022·0 cites·28 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter L. Collins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →